Thalidomide, deep venous thrombosis and vasculitis

被引：4

作者：

Silingardi, M ^{[1
]}

Iotti, M ^{[1
]}

Trenti, C ^{[1
]}

Salvarani, C ^{[1
]}

Iori, I ^{[1
]}

机构：

[1] Az Osped S Maria Nuova, Ctr Emostasi & Trombosi, UO Med Interna, Dipartimento Area Med, I-42100 Reggio Emilia, Italy

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2004年 / 2卷 / 11期

关键词：

D O I：

10.1111/j.1538-7836.2004.00952.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2062 / 2063

页数：2

共 7 条

[1] Thalidomide and thrombosis in multiple myeloma [J].

Barbui, T ;

Falanga, A .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (03) :421-422

[2] Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome - A randomized, double-blind, placebo-controlled trial [J].

Hamuryudan, V ;

Mat, C ;

Saip, S ;

Ozyazgan, Y ;

Siva, A ;

Yurdakul, S ;

Zwingenberger, K ;

Yazici, H .

ANNALS OF INTERNAL MEDICINE, 1998, 128 (06) :443-+

[3] Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment [J].

Minnema, MC ;

Fijnheer, R ;

De Groot, PG ;

Lokhorst, HM .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (03) :445-449

[4]

Ossandon A, 2002, CLIN EXP RHEUMATOL, V20, P709

[5] Thalidomide and thrombosis [J].

Rodeghiero, F ;

Elice, F .

PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2003, 33 :15-18

[6] Current concepts - Behcet's disease [J].

Sakane, T ;

Takeno, M ;

Suzuki, N ;

Inaba, G .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (17) :1284-1291

[7]

Salvarani C, 2000, J RHEUMATOL, V27, P515

← 1 →